looks like Taylor Collison are impressed...(latest update 9 pages)
Snapshot of the report:
FY19 Result CARR: $7.9M (up 42% YoY) and in-line with expectations.
New contract wins ($7.4M TCV) post-June 30 puts current CARR at $8.8M.
REVENUE: Growth of 8% to $9.3M (FY19e: $9.8M). TCV of new deals in FY19 was $21M, of which $15M is attributable to HKHA. Only $1.5M in revenue from this deal was recognised in FY19 so we anticipate a larger portion of the remaining $13.5M (minimum contracted value over 5 years) to be recognised in FY20.
EBITDA: The reported EBITDA loss appears higher than expected but is mostly offset by $332k in restructuring costs and a $772k reduction in share-based payments. The $1.6M payment to Client Outlook is a one-off although further licence fees will be payable for future contracts utilising the eUnity viewer.
FREE CASH FLOW BREAKEVEN: Our updated forecasts indicate the end of February 2020 target should be comfortably achievable.
imo, a buying opportunity atm...
Full report...(Courtesy ASX)
Ann: Preliminary Final Report, page-20
Add M7T (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
0.020(5.41%) |
Mkt cap ! $94.08M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 40.5¢ | 35.0¢ | $459.2K | 1.247M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 70000 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 48343 | 3 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| M7T (ASX) Chart |